Matinas BioPharma Holdings Inc (MTNB.A)

+ 收藏

财务摘要(报告期)(Matinas BioPharma Holdings Inc)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2024年中报2024年一季报2023年年报2023年三季报2023年中报2023年一季报2022年年报2022年三季报2022年中报2022年一季报
每股指标:
 每股收益EPS基本(元) -0.05-0.03-0.11-0.08-0.05-0.03-0.10-0.08-0.05-0.03
 每股净资产(元) 0.080.070.090.110.130.150.170.180.200.22
 每股经营现金净流量(元) -0.04-0.03-0.07-0.05-0.03-0.02-0.09-0.07-0.05-0.02
 每股现金流量净额(元) --0.02-0.01-0.01-0.01-0.07-0.05-0.05-0.01
 每股营业收入(元) --0.010.010.010.010.010.01--
盈利能力:
 销售毛利率(%) --100.00100.00100.00100.00100.00100.00100.00-
 销售净利率(%) ---2,093.25-1,608.39-1,055.93-503.01-658.63-817.06-1,120.08-
 净资产收益率平均(%) -60.20-34.46-82.11-58.97-35.89-15.92-47.11-38.11-24.96-11.94
 总资产净利率(%) -46.67-26.05-65.62-47.25-29.36-13.27-39.56-31.90-20.93-10.21
 投入资本回报率ROIC(%) -57.05-29.98-78.70-57.45-37.17-15.64-53.64-45.29-28.92-15.58
收益质量:
 营业利润/利润总额(%) 101.72101.34103.59101.42101.49101.32117.11110.07114.68129.17
 经营活动产生的现金流量净额/营业收入(%) ---1,393.98-976.19-572.99-372.90-600.88-699.14-930.63-
资本结构:
 资产负债率(%) 21.6025.7623.3322.2918.1414.7318.2618.7818.2514.53
 权益乘数 1.281.351.301.291.221.171.221.231.221.17
 产权比率 0.280.350.300.290.220.170.220.230.220.17
 流动资产/总资产(%) 62.7352.4761.9167.1070.5473.7277.0578.0379.9880.88
 非流动资产/总资产(%) 37.2747.5338.0932.9029.4626.2822.9521.9720.0219.12
 流动负债/负债合计(%) 45.4639.5544.7648.6241.9533.6352.3854.9156.2646.51
 非流动负债/负债合计(%) 54.5460.4555.2451.3858.0566.3747.6245.0943.7453.49
 归属母公司股东的权益/投入资本(%) 94.8178.5394.7399.00114.71100.3196.44106.18101.98130.79
偿债能力:
 流动比率 6.395.155.936.199.2714.888.067.577.7911.97
 速动比率 6.395.155.936.199.2714.888.067.577.7911.97
 货币资金/流动负债(%) 176.2553.60182.57198.42376.32302.69159.36228.00193.20512.89
 营业利润/流动负债(%) -490.89-295.40-906.41-553.70-453.65-294.62-573.73-389.88-253.57-204.92
 经营活动产生的现金流量净额/流动负债(%) -371.03-288.74-582.68-331.34-242.56-215.56-446.94-303.10-183.71-126.20
 归属母公司股东的权益/负债合计(%) 363.04288.16328.54348.59451.37578.77447.78432.62447.87588.43
 经营活动产生的现金流量净额/负债合计(%) -168.66-114.19-260.81-161.11-101.77-72.50-234.12-166.43-103.35-58.69
 营业利润/负债合计(%) -223.15-116.83-405.70-269.22-190.33-99.10-300.54-214.08-142.65-95.30
成长能力:
 总资产同比增长率(%) -28.39-48.75-43.99-37.34-35.09-31.41-26.92-29.02-25.09-22.90
 每股净资产同比增长率(%) -40.59-55.42-47.47-40.17-35.11-31.70-30.53-33.89-32.59-32.51
 总负债同比增长率(%) -14.73-10.38-28.40-25.61-35.50-30.43-7.362.2535.3739.84
 基本每股收益同比增长率(%) ---10.00-16.67-9.09---
 归属母公司股东的权益同比增长率(%) -31.42-55.38-47.47-40.06-34.99-31.58-30.21-33.71-31.88-28.36
 营业利润同比增长率(%) 0.03-5.663.356.4413.9427.660.59-6.05-22.48-21.55
 营业收入同比增长率(%) -100.00-100.00-65.62-48.423.10-9,560.616,275.063,087.53-100.00
 股东权益合计同比增长率(%) -31.42-55.38-47.47-40.06-34.99-31.58-30.21-33.71-31.88-28.36
营运能力:
 流动资产周转率次(次) --0.040.040.040.030.070.050.02-
 固定资产周转率次(次) --0.550.530.520.541.761.150.60-
 总资产周转率次(次) --0.030.030.030.030.060.040.02-
衍生指标:
 现金及现金等价物净增加额TTM(元) -5,527,000.00-4,668,000.00-2,043,000.00-4,769,000.00-656,000.00-13,589,000.00-14,200,000.00-13,746,922.00-20,039,815.00-4,140,608.00
 利润总额TTM(元) -22,912,000.00-23,253,000.00-22,942,000.00-21,262,000.00-20,669,000.00-20,532,000.00-20,997,000.00-24,061,889.00-25,436,847.00-24,305,368.00
 毛利TTM(元) 1,096,000.001,096,000.001,096,000.002,159,000.003,221,000.003,188,000.003,188,000.002,125,000.001,062,500.00-1,736,673.00
 投入资本(元) 20,149,000.0018,539,000.0020,317,000.0023,384,000.0024,282,000.0032,523,000.0037,989,000.0036,369,825.0042,017,097.0036,456,730.00
 经营活动产生的现金流量净额TTM(元) -17,873,000.00-16,960,000.00-15,278,000.00-14,998,000.00-15,549,000.00-18,487,000.00-19,156,000.00-18,814,339.00-19,595,599.00-15,328,017.00
 总营业收入TTM(元) 1,096,000.001,096,000.001,096,000.002,159,000.003,221,000.003,188,000.003,188,000.002,125,000.001,062,500.0033,333.00
 归属母公司净利润TTM(元) -22,912,000.00-23,253,000.00-22,942,000.00-21,262,000.00-20,669,000.00-20,532,000.00-20,997,000.00-24,061,889.00-25,436,847.00-24,305,368.00

前瞻产业研究院